PROJECT

Projects

Summary of Investment Information

Project Number

50258

Company Name

POPULAR PHARMACEUTICALS LTD

Date SPI Disclosed

Jan 6, 2026

Country

Bangladesh

Region

South Asia

Projected Board Date

Feb 5, 2026

Environmental Category

B - Limited

Status

Pending Approval

Last Updated Date

Jan 6, 2026

Department

Regional Industry - MAS Asia & Pac

Industry

other

Sector

Pharmaceuticals and Medicine Manufacturing

Project Description

 The proposed investment is for up to US$30.7 million (“IFC Loan”) to Popular Pharmaceuticals PLC. (“PPL” or the “Company” or the “Borrower”) in Bangladesh.

Founded in 2006, PPL is a well-established, mid-sized pharmaceutical manufacturer in Bangladesh. The Company ranks 9th by revenue in Bangladesh pharma market. PPL belongs to Popular Group, which is a leading, family-owned healthcare conglomerate in Bangladesh with a 41-year track record across diagnostics, pharmaceuticals, hospitals, and medical education

The IFC Loan proceeds will be used to finance working capital, primarily for the procurement of raw materials, which are mostly imported. The transaction aims to ensure uninterrupted supply of essential medicines during a period of financial sector stress and credit tightening in Bangladesh. A long-term US$-denominated loan will enable the Company to navigate the current financial sector stress and credit tightness and maintain continuity of operations.

Associated Advisory Engagement

IFC will support PPL to improve gender diversity and inclusion in their workplace by providing recommendations, guidance, and tools to improve policies and practices to support workplace participation of all genders, particularly women through gender advisory.                                                   

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation